Investment analysts and portfolio managers look into their crystal balls to predict the best-performing stocks for the year ahead.
Peter Meintjes has track record for commercialising disruptive biotech, company says.
But acting chief executive Liam Mason concedes it has real concerns about sector.
UPDATE: Shares plunge 10% as market reacts.
Angel at My Table: Early-stage deals were up 60% in the first half of 2021.
Companies stay positive as regulator focuses on local market.
Harbour Asset Management portfolio manager Shane Solly on the week ahead.
Deal takes portfolio to 10,800ha of dairy assets.
Although NZ business likely to take a little longer to recover.
Construction group eyes ’robust bounce back’ as restrictions ease.
